Zentalis Pharmaceuticals, Inc. Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc.

ZNTL

Rank in Stocks #17951
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company,... Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Share Price
$1.70
Last synced: 2026-11-13
Market Cap
$143.84M
Change (1 day)
1.19%
Change (1 year)
26.87%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Zentalis Pharmaceuticals, Inc. (ZNTL)

Category

Healthcare
Operating Margin for Zentalis Pharmaceuticals, Inc. (ZNTL)
Operating Margin as of November 2026 TTM: 0.00%
According to Zentalis Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Zentalis Pharmaceuticals, Inc. from 2018 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% -100.00%
2024 -283.57% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% -100.00%
2018 -169,878.57% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -
US
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Zentalis Pharmaceuticals, Inc.'s operating margin

What was Zentalis Pharmaceuticals, Inc.'s operating margin in 2025?

In 2025, Zentalis Pharmaceuticals, Inc.'s operating margin was 0.00%, compared with -283.57% in 2024.

How has Zentalis Pharmaceuticals, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Zentalis Pharmaceuticals, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-283.57%).

How does Zentalis Pharmaceuticals, Inc.'s operating margin compare with similar companies?

Zentalis Pharmaceuticals, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.